Allianz Asset Management Gmb H I Teos Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$9.89 - $13.64 $203,160 - $280,192	20,542 New	20,542 $280,000
Q3 2023 Nov 13, 2023	SELL	$10.95 - $14.6 $252,802 - $337,070	-23,087 Reduced 41.76%	32,200 $352,000
Q2 2023 Aug 11, 2023	BUY	$12.93 - $18.05 $324,646 - $453,199	25,108 Added 83.2%	55,287 $731,000
Q1 2023 May 11, 2023	BUY	$13.02 - $22.62 $392,930 - $682,648	30,179 New	30,179 $410,000
Q2 2022 Aug 12, 2022	BUY	$16.57 - $35.1 $196,586 - $416,426	11,864 New	11,864 $244,000

165

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $293M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.